Epilepsia

Volume 40, Issue 8 p. 1171

Letters to the Editor

C P Panayiotopoulos, 

C P Panayiotopoulos

Department of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London, UK.

Search for more papers by this author

C P Panayiotopoulos, 

C P Panayiotopoulos

Department of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London, UK.

Search for more papers by this author

First published: 02 August 2005

https://doi.org/10.1111/j.1528-1157.1999.tb00840.x

Citations: 3

No abstract is available for this article.

REFERENCES

• 1 Beran RG, Berkovic SF, Dunagan FM, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 1998; 39: 1329–33.
  10.1111/j.1528-1157.1998.tb01332.x

  CAS PubMed Web of Science® Google Scholar
• 2 Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO. Interaction of lamotrigine with sodium valproate. Lancet 1993; 341: 445.
  10.1016/0140-6736(93)93048-6

  CAS PubMed Web of Science® Google Scholar
• 3 Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 1995; 91: 200–2.
  10.1111/j.1600-0404.1995.tb00434.x

  CAS PubMed Web of Science® Google Scholar
• 4 Coultier DA. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in. J Child Neurol 1997; 12: (Suppl. 1): S2–9.
  10.1177/0883073897012001031

  PubMed Web of Science® Google Scholar

Citing Literature

Volume40, Issue8

August 1999

Page 1171

• References

• Related

• Information

Close Figure Viewer

Previous FigureNext Figure

Caption

Download PDF